WallStreetZenWallStreetZen

NASDAQ: CVKD
Cadrenal Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Cadrenal Therapeutics earnings were -$11.9M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest CVKD earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$2.5M, down 17.8% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, CVKD reported annual earnings of -$13.2M, with 24.3% growth. The next CVKD earnings date is Aug 10, 2026.

CVKD earnings history

Current Revenue
$0.0
Current Earnings
-$11.9M
Current Profit Margin
0%

CVKD Return on Equity

Current Company
-411%
Current Industry
-141.9%
Current Market
13.5%
CVKD's Return on Equity (-411%)... subscribe to Premium to read more.
High Return on Equity Performance

CVKD Return on Assets

Current Company
-275.6%
Current Industry
-13.7%
CVKD is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when CVKD announces earnings.

CVKD Return on Capital Employed

Current Company
-661.53%
Current Industry
-9.6%
CVKD's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CVKD vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
CVKD-$11.89M-$11.89MN/A-$5.63
VTGN-$68.95M-$69.69MN/A-$1.83
BRTX-$10.85M-$11.06MN/A-$1.07
CVM-$18.35M-$22.70MN/A-$2.22
OSRH-$7.28k-$12.49k-100.00%$0.00
View Top Biotech Stocks

CVKD earnings dates

Next earnings date
Aug 10, 2026

Cadrenal Therapeutics Earnings Reports & History FAQ

What were Cadrenal Therapeutics's earnings last quarter?

Cadrenal Therapeutics (NASDAQ: CVKD) reported Q1 2026 earnings per share (EPS) of -$1.04, up 50.24% year over year. Total CVKD earnings for the quarter were -$2.50 million. In the same quarter last year, Cadrenal Therapeutics's earnings per share (EPS) was -$2.09.

If you're new to stock investing, here's how to buy Cadrenal Therapeutics stock.

When does Cadrenal Therapeutics report earnings?

The next CVKD earnings date is Invalid Date. Add CVKD to your watchlist to be reminded of Cadrenal Therapeutics's next earnings date.

Is Cadrenal Therapeutics profitable or losing money?

As of the last Cadrenal Therapeutics earnings report, Cadrenal Therapeutics is currently losing money. Cadrenal Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$11.89 million, a 7.36% decrease year over year.

What was CVKD's earnings growth in the past year?

As of Cadrenal Therapeutics's earnings date in Q3 2026, Cadrenal Therapeutics's earnings has grown year over year. CVKD earnings in the past year totalled -$11.89 million.

What are Cadrenal Therapeutics's earnings expectations?

The current EPS estimate for Cadrenal Therapeutics's earnings report in Invalid Date is -$1.55.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.